Skip to main content
41°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Personalis, Inc.
< Previous
1
2
3
Next >
Personalis to Participate at Upcoming Investor Conferences
November 20, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Reports Third Quarter 2024 Financial Results
November 06, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Present at the Stifel 2024 Healthcare Conference
November 05, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Announce Third Quarter 2024 Financial Results
October 23, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test
September 16, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Participate at Upcoming Investor Conferences
August 22, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 19, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis and Tempus Announce Expanded Collaboration
August 16, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Reports Second Quarter 2024 Financial Results
August 07, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Participate at the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
July 31, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Announce Second Quarter 2024 Financial Results
July 24, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference
June 18, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call
June 13, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring
June 04, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus
May 31, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024
May 22, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Reports First Quarter 2024 Financial Results
May 08, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Announce First Quarter 2024 Financial Results
April 24, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference
March 28, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
March 28, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
March 26, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 19, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Reports Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results
February 14, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis to Participate at Upcoming Investor Conferences
January 31, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology
January 30, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 17, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay
January 16, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
Personalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash Balance
January 05, 2024
From
Personalis, Inc.
Via
Business Wire
Tickers
PSNL
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
